Home・Akcijų sąrašas・Zoetis Inc

Zoetis Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

77.9 0.72

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

76.87

Max

77.51

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-2M 601M
Pardavimai	-125M 2.3B
P/E Sektoriaus vid.	12.61 64.641
Pelnas, tenkantis vienai akcijai	1.53
Dividendų pajamingumas	2.69
Pelno marža	26.569
Darbuotojai	14,500
EBITDA	-8M 939M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+28.58% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	2.69% 2.31%
Kitas uždarbis	2026-08-06
Kitas dividendų mokėjimo data	2026-09-01
Kita Ex Dividend data	2026-10-30

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-16B 32B
Ankstesnė atidarymo kaina	77.18
Ankstesnė uždarymo kaina	77.9

Naujienos nuotaikos

By Acuity

59%

41%

275 / 340 reitingas Healthcare

Zoetis Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-01 00:01; UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

2026-07-31 23:06; UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

2026-07-30 19:03; UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

2026-07-29 22:51; UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

2026-07-28 23:02; UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

2026-07-27 23:16; UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

2026-07-25 00:01; UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

2026-07-24 21:02; UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

2026-07-23 20:02; UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

2026-07-22 21:02; UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

2026-07-21 17:51; UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

2026-07-20 23:16; UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Akcijų palyginimas

Kainos pokytis

Zoetis Inc Prognozė

Kainos tikslas

By TipRanks

28.58% į viršų

12 mėnesių prognozė

Vidutinis 99.38 USD 28.58%

Aukščiausias 130 USD

Žemiausias 85 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zoetis Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių Zoetis Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

275 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.